A detailed history of Mountain Pacific Investment Advisers Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 9,448 shares of PFE stock, worth $251,505. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,448
Previous 9,229 2.37%
Holding current value
$251,505
Previous $258,000 5.81%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.7 - $31.39 $6,066 - $6,874
219 Added 2.37%
9,448 $273,000
Q2 2024

Jul 10, 2024

SELL
$25.26 - $29.6 $9,851 - $11,544
-390 Reduced 4.05%
9,229 $258,000
Q1 2024

Apr 11, 2024

SELL
$25.89 - $29.73 $18,977 - $21,792
-733 Reduced 7.08%
9,619 $266,000
Q4 2023

Feb 02, 2024

BUY
$26.13 - $33.94 $3,919 - $5,091
150 Added 1.47%
10,352 $298,000
Q3 2023

Oct 20, 2023

SELL
$32.09 - $37.51 $65,142 - $76,145
-2,030 Reduced 16.6%
10,202 $338,000
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $4,695 - $5,432
130 Added 1.07%
12,232 $448,000
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $12,525 - $16,350
-300 Reduced 2.42%
12,102 $0
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $10,515 - $12,468
-226 Reduced 1.79%
12,402 $650,000
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $3,431 - $4,251
75 Added 0.6%
12,628 $654,000
Q4 2021

Jan 19, 2022

SELL
$41.32 - $61.25 $20,660 - $30,625
-500 Reduced 3.83%
12,553 $741,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $136,027 - $154,095
-3,788 Reduced 22.49%
13,053 $511,000
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $36,336 - $40,980
1,085 Added 6.89%
16,841 $610,000
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $17,002 - $21,620
508 Added 3.33%
15,756 $580,000
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $28,575 - $33,525
900 Added 6.27%
15,248 $560,000
Q2 2020

Jul 09, 2020

BUY
$30.12 - $36.54 $66,264 - $80,388
2,200 Added 18.11%
14,348 $469,000
Q1 2020

Apr 08, 2020

SELL
$27.03 - $38.62 $3,513 - $5,020
-130 Reduced 1.06%
12,148 $397,000
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $34,170 - $38,779
-1,038 Reduced 7.8%
12,278 $481,000
Q2 2019

Jul 23, 2019

SELL
$36.98 - $41.52 $16,677 - $18,725
-451 Reduced 3.28%
13,316 $577,000
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $9,337 - $10,258
-249 Reduced 1.78%
13,767 $585,000
Q1 2018

Apr 30, 2018

SELL
$31.91 - $37.02 $5,488 - $6,367
-172 Reduced 1.21%
14,016 $497,000
Q4 2017

Jan 23, 2018

SELL
$33.26 - $35.29 $24,945 - $26,467
-750 Reduced 5.02%
14,188 $514,000
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $463,078 - $510,132
14,938
14,938 $533,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.